Watchlist Price Alert

XTL Biopharmaceuticals Lt... (XTLB)

NASDAQ: XTLB · Real-Time Price · USD

1.25

0.03 (2.46%)

At close: Jun 17, 2025, 12:16 PM

XTL Biopharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-1.03M	-1.78M	-1.35M	435K	-2.95M	-1.35M	2.99M	-781K	-2.54M
Depreciation & Amortization	199K	n/a	1K	1K	1K	n/a	n/a	1K	3K
Stock-Based Compensation	264K	3K	14K	37K	51K	5K	24K	40K	182K
Other Working Capital	-58K	45K	25K	-31K	23K	-29K	39K	65K	-119K
Other Non-Cash Items	-1.11M	1.01M	-36K	-1.47M	2.01M	484K	-3.82M	-437K	848K
Deferred Income Tax	-130K	n/a	487K	n/a	n/a	n/a	n/a	-755K	-182K
Change in Working Capital	189K	64K	-19K	-54K	45K	-50K	-8K	52K	-220K
Operating Cash Flow	-1.62M	-707K	-901K	-1.05M	-850K	-908K	-816K	-1.13M	-1.73M
Capital Expenditures	-54K	n/a	n/a	n/a	-1K	-2K	n/a	n/a	-66K
Cash Acquisitions	-410K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-14K	n/a	n/a	n/a	n/a	n/a	-6.3M	-2.5M	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	2.02M	7M	n/a	n/a
Other Investing Acitivies	-366K	41K	36K	8K	33K	93K	74K	5K	-64K
Investing Cash Flow	-844K	41K	36K	8K	32K	2.11M	778K	-2.5M	-66K
Debt Repayment	-13K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	385K	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	1.45M	n/a	n/a	385K	n/a	n/a	n/a	4.89M	n/a
Net Cash Flow	-1.03M	-693K	-875K	-662K	-824K	1.2M	-34K	1.27M	-1.8M
Free Cash Flow	-1.67M	-707K	-901K	-1.05M	-851K	-910K	-816K	-1.13M	-1.8M